NovaMedica is sharing knowledge
29 September 2015
NovaMedica actively involved in RNOF-2015 (Russian National Ophthalmological Forum) that took place in Moscow, September 23, 2015. This is one of the most important educational events in ophthalmology.
22 September 2015
September 17, 2015, Moscow held IBD School (Inflammatory Bowel Disorder School) chaired by the head gastroenterologist of the Moscow Region, Professor Elena Belousova. NovaMedica was the general partner of this educational event that brought together over 100 gastroenterologists from Moscow and other regions of Russia.
NovaMedica opens the program of scientific-practical events for Russian gastroenterologists
16 July 2015
Russian pharmaceutical company NovaMedica takes an active part in the V Baikal Forum on Inflammatory Bowel Diseases (IBD), which befalls from 16 to 18 of July in Irkutsk. Participating in this event NovaMedica opens a series of scientific and practical programs for the professional community of gastroenterologists.
22 June 2015
June 25, 2015, Vedomosti newspaper office will host a FocusForum Conference in Moscow with a leading participation of Leonid Melamed, the Chairman of Team Drive, member of the Board of Directors of NovaMedica, RMI Partners and Doctor Ryadom. The conference’s goal is to gather experts and share ideas and valuable experience in the time of business challenges. In his video interview to Vedomosti, Leonid explained his vision of the company management tasks in the period of uncertainty.
NovaMedica is planning to create around 15 innovative nanotech-involved pharmaceutical products
18 June 2015
A Russian pharmaceutical company NovaMedica is planning to grow its R&D activities targeted at building a portfolio of proprietary nanotech-involving pharmaceutical products. This is what has been announced today by Vladimir Gurdus, General Manager at RMI Partners, managing company of NovaMedicw, at the Annual Saint Petersburg International Economic Forum during his panel discussion titled “Nanotechnologies – meeting the expectations?”
18 June 2015
NovaMedica has taken part in the Russian panel discussion on BIO-2015 in Philadelphia (USA). The session “Reaching Out to Russia: The Biotech R&D Landscape and Global Drug Discovery Case Studies. Emerging Opportunities in Global Markets” was organized by Skolkovo Foundation.
NovaMedica Starts its First Media Campaign
10 June 2015
Russian pharmaceutical company NovaMedica has started its first TV and Internet media campaign targeted at promotion of innovative gastroenterological products under an umbrella brand “Benegast”. Media campaign includes rotation of video commercials produced by BAZELEVS, a movie company owned by a famous director Timur Bekmambetov.
02 June 2015
NovaMedica, a Russian pharmaceutical company, and Ferring Pharmaceuticals, a Swiss-based global biopharmaceutical company, have signed an agreement, that gives NovaMedica the rights for commercialization of a range of Ferring’s line of innovative gastroenterological prescription drug products for the treatment of inflammatory bowel disease (IBD) in the Russian market.
NovaMedica is Expanding Ophta Horizons
27 May 2015
NovaMedica, a Russian pharmaceutical company, participated in the White Nights-2015 International Ophthalmology Congress and hosted a satellite symposium “NovaMedica: New Ophta Horizons”. The symposium was started by Boris Malyugin, Deputy General Director for Science at MNTK “Eye Microsurgery” named after Federov S.N., and presented the first publication of in vitro research results on potency of netilmicin and reference drug products.
People, medicines and venture investments
13 April 2015
April 6-10, 2015, Moscow hosted the 22nd Russian National Congress “People and Medicines”. NovaMedica have actively participated in R&D part of its program and organized a symposium “Venture investments in Research and Development” chaired by Mikhail Getman, Vice President for Pharmaceutical Operations at NovaMedica.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russia has expanded the mandatory health insurance program for 2024-2026
29 March 2024
Russian scientists have developed new TB vaccines for both injection and nasal administration.
29 March 2024
The overall mortality rate of the population in Russia decreased by 7% in 2023
28 March 2024
Russia to collaborate with Hungary and Serbia in nuclear medicine
28 March 2024